There was discussion at the August meeting of a drug called Rituxin, which is a genetically engineered mouse antibody. Click on the headline above to read an FDA press release from last November. More information can be found at the website of Genentech, the co-producers of Rituxan. A third, independent review of the drug can be found at the Medical Sciences Bulletin website.